ebv-positive dlbcl, nos Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 1/2 (1)

Interventional (1)

Huiqiang Huang (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadb-cell lymphoma

I am/have/hadebv-positive dlbcl, nos

I am/have/hadtubal ligation

I am/have/hadaptt

I am/have/haddifficulty breathing at rest

I am/have/hadblood transfusion

I am/have/hadfollicular lymphoma grade iiib

I am/have/hadlymphoma

I am/have/hadimmunodeficiency

I am/have/hadneutrophil count

I am/have/hadanticoagulant therapy

I am/have/hadfollicular lymphoma

I am/have/hadct scan

I am/have/hadplatelet count

I am/have/hadserum bilirubin

I am/have/hadprothrombin time (pt)

I am/have/hadpulse oximetry

I am/have/hadthyroid dysfunction

I am/have/hadmeasurable disease

I am/have/hadpositron emission tomography

added new label for I am/have/had

more

I am looking for

I am looking forrituximab

I am looking forcolony stimulating factor

I am looking forgranulocyte colony stimulating factor

I am looking fororal contraceptives

I am looking foranticoagulants

I am looking for18f-fdg

I am looking forapatinib

I am looking forcamrelizumab

I am looking forg-csf

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Camrelizumab in Combination With Apatinib in Refractory and Relapsed DLBCL

This study will evaluate the efficacy and safety of camrelizumab in combination with apatinib in in patients with relapsed or refractory diffuse large B cell lymphoma failed from second line chemotherapy.

rituximab

b-cell lymphoma

difficulty breathing at rest

follicular lymphoma grade iiib

blood transfusion

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.